Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39362 | 1.00 | NR1I2 (0.39) | NR1I2LMNAPGR | |
| SCHEMBL2837836 | 0.93 | NR1I2 (0.46) | NR1I2LMNAPGR | |
| SCHEMBL2837930 | 0.92 | LMNA (0.41) | NR1I2LMNAPGR | |
| SCHEMBL2836685 | 0.85 | LMNA (0.48) | NR1I2LMNAPGR | |
| SCHEMBL2832158 | 0.85 | NR1I2 (0.51) | NR1I2LMNAPGR | |
| SCHEMBL22117353 | 0.83 | ALDH1A1 (0.35) | NR1I2LMNAPGR | |
| SCHEMBL2834863 | 0.83 | LMNA (0.47) | NR1I2LMNAPGR | |
| SCHEMBL504504 | 0.83 | ALDH1A1 (0.39) | NR1I2LMNAPGR | |
| SCHEMBL504505 | 0.83 | ALDH1A1 (0.39) | NR1I2LMNAPGR | |
| SCHEMBL2840460 | 0.82 | NR1I2 (0.50) | NR1I2LMNAPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897677-A1 | COMPOSITION FOR USE IN A METHOD FOR LOWERING OF LDL-CHOLESTEROL IN PLASMA | ezCol B.V. (NL) | 2021-10-27 | — | — | EP | claimed |
| US-20210275601-A1 | LDL-CHOLESTEROL-LOWERING CELL EXTRACT AND FOOD SUPPLEMENT | EZCOL B.V. (NL) | 2021-09-09 | — | — | US | claimed |
| US-11026981-B2 | LDL-cholesterol-lowering cell extract and food supplement | EZCOL B.V. (NL) | 2021-06-08 | — | — | US | claimed |
| WO-2020130813-A1 | COMPOSITION FOR USE IN A METHOD FOR LOWERING OF LDL-CHOLESTEROL IN PLASMA | EZCOL B.V. (NL) | 2020-06-25 | — | — | WO | claimed |
| EP-3638272-A1 | LDL-CHOLESTEROL-LOWERING CELL EXTRACT AND FOOD SUPPLEMENT | ezCol B.V. (NL) | 2020-04-22 | — | — | EP | claimed |
| US-20200101120-A1 | LDL-CHOLESTEROL-LOWERING CELL EXTRACT AND FOOD SUPPLEMENT | EZCOL B.V. (NL) | 2020-04-02 | — | — | US | claimed |
| WO-2018229223-A1 | LDL-CHOLESTEROL-LOWERING CELL EXTRACT AND FOOD SUPPLEMENT | EZCOL B.V. (NL) | 2018-12-20 | — | — | WO | claimed |
| CN-103120798-A | Preparation method and application of phospholipid complex with anti-oxidative stress | SHI DONGYUN | 2013-05-29 | — | — | CN | claimed |
| CN-102584584-A | Conjugated polyene fatty acid polyphenol ester, carotenoid ester, anthocyanin ester derivative and purposes thereof | UNIV HENAN NORMAL | 2012-07-18 | — | — | CN | claimed |
| CN-1948400-A | Preparation method of microbial natural pigment | HUNAN POLYTECHNIC UNIV (CN) | 2007-04-18 | — | — | CN | claimed |
| US-20260144834-A1 | ANTIMICROBIAL FEED ADDITIVE | Axitan Ltd. (GB) | 2026-05-28 | — | — | US | disclosed |
| US-20260123660-A1 | Particles Containing a Lipid Matrix Core and Active Ingredient | LONZA SALES AG (CH) | 2026-05-07 | — | — | US | disclosed |
| EP-4054348-B1 | PARTICLES CONTAINING A LIPID MATRIX CORE AND ACTIVE INGREDIENT | LONZA SALES AG (CH) | 2026-01-28 | — | — | EP | disclosed |
| US-12471609-B2 | Reducing the risk of viral infection due to viral contaminated feed | NOVUS INTERNATIONAL, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-12465075-B2 | Particles containing a lipid matrix core and active ingredient | LONZA SALES AG (CH) | 2025-11-11 | — | — | US | disclosed |
| US-5919762-A | Conjugates of hirudin and lipophilic compounds | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-06 | — | — | US | disclosed |
| CN-1142776-A | Hirudin conjugates from hirudin and lipophilic compounds | BASF AG (DE) | 1997-02-12 | — | — | CN | disclosed |
| EP-0730473-A1 | HIRUDIN CONJUGATES FROM HIRUDIN AND LIPOPHILIC COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1996-09-11 | — | — | EP | disclosed |
| WO-1996012505-A1 | CONJUGATES OF A POLYPEPTIDE OR OLIGOPEPTIDE WITH A LOW MOLECULAR WEIGHT LIPOPHILIC COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 1996-05-02 | — | — | WO | disclosed |
| WO-1995015183-A1 | HIRUDIN CONJUGATES FROM HIRUDIN AND LIPOPHILIC COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1995-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144834-A1 | ANTIMICROBIAL FEED ADDITIVE | ELOVL6, CROCC, ELOC | NR1I2 1086/4885LMNA 2049/4885PGR 4682/4885 |
| US-20260123660-A1 | Particles Containing a Lipid Matrix Core and Active Ingredient | AUP1, MGLL, MBOAT4 | NR1I2 2608/4885LMNA 1876/4885PGR 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.